173 related articles for article (PubMed ID: 28755163)
21. Sustained virological response halts fibrosis progression: A long-term follow-up study of people with chronic hepatitis C infection.
Chen Yi Mei SLG; Thompson AJ; Christensen B; Cunningham G; McDonald L; Bell S; Iser D; Nguyen T; Desmond PV
PLoS One; 2017; 12(10):e0185609. PubMed ID: 29065124
[TBL] [Abstract][Full Text] [Related]
22. Noninvasive Assessment of Liver Fibrosis By Transient Elastography and FIB4/APRI for Prediction of Treatment Response in Chronic Hepatitis C-An Experience from a Tertiary Care Hospital.
Taneja S; Tohra S; Duseja A; Dhiman RK; Chawla YK
J Clin Exp Hepatol; 2016 Dec; 6(4):282-290. PubMed ID: 28003717
[TBL] [Abstract][Full Text] [Related]
23. Declining in liver stiffness cannot indicate fibrosis regression in patients with chronic hepatitis B: A 78-week prospective study.
Dong XQ; Wu Z; Li J; Wang GQ; Zhao H;
J Gastroenterol Hepatol; 2019 Apr; 34(4):755-763. PubMed ID: 30290019
[TBL] [Abstract][Full Text] [Related]
24. The Association of PNPLA3, COX-2 and DHCR7 Polymorphisms with Advanced Liver Fibrosis in Patients with HCV Mono- Infection and HCV/HIV Co-Infection.
Kiatbumrung R; Chuaypen N; Payungporn S; Avihingsanon A; Tangkijvanich P
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2191-2197. PubMed ID: 30139224
[TBL] [Abstract][Full Text] [Related]
25. PNPLA3 rs738409 polymorphism is associated with liver fibrosis progression in patients with chronic hepatitis C: A repeated measures study.
Jiménez-Sousa MÁ; Gómez-Moreno AZ; Pineda-Tenor D; Sánchez-Ruano JJ; Fernández-Rodríguez A; Artaza-Varasa T; Gómez-Sanz A; Martín-Vicente M; Vázquez-Morón S; Resino S
J Clin Virol; 2018 Jun; 103():71-74. PubMed ID: 29674183
[TBL] [Abstract][Full Text] [Related]
26. High proportions of liver fibrosis and cirrhosis in an ageing population of people who use drugs in Amsterdam, The Netherlands.
van Santen DK; Schim van der Loeff MF; Cartier van Dissel J; Martens JPD; van der Valk M; Prins M
Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1168-1176. PubMed ID: 30028776
[TBL] [Abstract][Full Text] [Related]
27. Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA experience.
Dolmazashvili E; Abutidze A; Chkhartishvili N; Karchava M; Sharvadze L; Tsertsvadze T
Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1223-1230. PubMed ID: 28857900
[TBL] [Abstract][Full Text] [Related]
28. How intrahepatic cholestasis affects liver stiffness in patients with chronic hepatitis B: a study of 1197 patients with liver biopsy.
Guo H; Liao M; Jin J; Zeng J; Li S; Schroeder DR; Zheng J; Zheng R; Chen S
Eur Radiol; 2020 Feb; 30(2):1096-1104. PubMed ID: 31673836
[TBL] [Abstract][Full Text] [Related]
29. Risk of liver decompensation among HIV/hepatitis C virus-coinfected individuals with advanced fibrosis: implications for the timing of therapy.
Macías J; Márquez M; Téllez F; Merino D; Jiménez-Aguilar P; López-Cortés LF; Ortega E; von Wichmann MA; Rivero A; Mancebo M; Santos J; Pérez-Pérez M; Suárez-Lozano I; Romero-Palacios A; Torres-Cornejo A; Pineda JA
Clin Infect Dis; 2013 Nov; 57(10):1401-8. PubMed ID: 23946224
[TBL] [Abstract][Full Text] [Related]
30. Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter?
Behairy Bel-S; Sira MM; Zalata KR; Salama el-SE; Abd-Allah MA
World J Gastroenterol; 2016 Apr; 22(16):4238-49. PubMed ID: 27122674
[TBL] [Abstract][Full Text] [Related]
31. Outreach screening of drug users for cirrhosis with transient elastography.
Moessner BK; Jørgensen TR; Skamling M; Vyberg M; Junker P; Pedersen C; Christensen PB
Addiction; 2011 May; 106(5):970-6. PubMed ID: 21182552
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C virus (HCV) related liver fibrosis in people who inject drugs (PWID) at the Stockholm Needle Exchange - evaluated with liver elasticity.
Kåberg M; Edgren E; Hammarberg A; Weiland O
Scand J Gastroenterol; 2019 Mar; 54(3):319-327. PubMed ID: 30907178
[No Abstract] [Full Text] [Related]
33. Liver stiffness-based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapy.
Wang JH; Yen YH; Yao CC; Hung CH; Chen CH; Hu TH; Lee CM; Lu SN
Liver Int; 2016 Dec; 36(12):1793-1799. PubMed ID: 27254286
[TBL] [Abstract][Full Text] [Related]
34. Toll-like receptor 8 (TLR8) polymorphisms are associated with non-progression of chronic hepatitis C in HIV/HCV coinfected patients.
Fernández-Rodríguez A; Berenguer J; Jiménez-Sousa MA; García-Álvarez M; Aldámiz-Echevarría T; Pineda-Tenor D; Diez C; de la Barrera J; Bellon JM; Briz V; Resino S
Infect Genet Evol; 2015 Dec; 36():339-344. PubMed ID: 26455634
[TBL] [Abstract][Full Text] [Related]
35. Impact of hepatitis C virus genotype-4 eradication following direct acting antivirals on liver stiffness measurement.
Tag-Adeen M; Sabra AM; Akazawa Y; Ohnita K; Nakao K
Hepat Med; 2017; 9():45-53. PubMed ID: 29062242
[TBL] [Abstract][Full Text] [Related]
36. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis.
Corpechot C; Gaouar F; El Naggar A; Kemgang A; Wendum D; Poupon R; Carrat F; Chazouillères O
Gastroenterology; 2014 Apr; 146(4):970-9; quiz e15-6. PubMed ID: 24389304
[TBL] [Abstract][Full Text] [Related]
37. Performance of transient elastography in assessing liver fibrosis in patients with autoimmune hepatitis-primary biliary cholangitis overlap syndrome.
Wu HM; Sheng L; Wang Q; Bao H; Miao Q; Xiao X; Guo CJ; Li H; Ma X; Qiu DK; Hua J
World J Gastroenterol; 2018 Feb; 24(6):737-743. PubMed ID: 29456412
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of transient elastography in assessing liver fibrosis in patients with autoimmune hepatitis.
Xu Q; Sheng L; Bao H; Chen X; Guo C; Li H; Ma X; Qiu D; Hua J
J Gastroenterol Hepatol; 2017 Mar; 32(3):639-644. PubMed ID: 27505153
[TBL] [Abstract][Full Text] [Related]
39. Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection.
Zeremski M; Dimova R; Brown Q; Jacobson IM; Markatou M; Talal AH
J Infect Dis; 2009 Dec; 200(11):1774-80. PubMed ID: 19848607
[TBL] [Abstract][Full Text] [Related]
40. Liver stiffness measurement in patients with cirrhosis and hepatocellular carcinoma: a case-control study.
Nahon P; Kettaneh A; Lemoine M; Seror O; Barget N; Trinchet JC; Beaugrand M; Ganne-Carrié N
Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):214-9. PubMed ID: 19212210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
